Literature DB >> 19933930

Angina symptoms are associated with mortality in older women with ischemic heart disease.

Janneke Berecki-Gisolf1, Lindy Humphreyes-Reid, Andrew Wilson, Annette Dobson.   

Abstract

BACKGROUND: Angina symptoms have been reported to predict mortality in men. The aim of this study was to investigate the association between angina symptoms and mortality in women. METHODS AND
RESULTS: In 2004, 873 older participants in the Australian Longitudinal Study on Women's Health with self-reported ischemic heart disease participated in a nested substudy. Women were 77 to 83 years of age; 165 (19%) died during the 4.5-year follow-up. Angina symptoms were established with Seattle Angina Questionnaire (SAQ) scores for physical limitation, angina frequency, angina stability, and disease perception. Proportional hazards modeling was used to examine the relationship of SAQ score differences with mortality. Physical limitation scores were associated with mortality, with hazard ratios of 1.1, 1.9, and 3.4 for mild, moderate, and severe versus minimal limitations, respectively (P<0.001). Angina frequency scores were also associated with death, with hazard ratios of 1.2, 1.2, and 4.8 for mild, moderate, and severe versus minimal angina frequency, respectively (P<0.001). Age (hazard ratio 1.1, 95% confidence interval 1.0 to 1.2), pulmonary disease (hazard ratio 1.6, 95% confidence interval 1.2 to 2.3), and kidney disease (hazard ratio 1.7, 95% confidence interval 1.1 to 2.5) were statistically significantly associated with mortality in a multivariable model of clinical predictors. In a combined model with SAQ scores and clinical predictors, SAQ scores for physical limitation and angina stability remained statistically significantly associated with mortality.
CONCLUSIONS: In older women with ischemic heart disease, angina symptoms assessed by use of SAQ scores for physical limitations and angina frequency were associated with mortality; SAQ scores may therefore prove to be a useful tool for risk assessment in this patient group.

Entities:  

Mesh:

Year:  2009        PMID: 19933930     DOI: 10.1161/CIRCULATIONAHA.109.887380

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients.

Authors:  Mohammad Bilal Siddiqui; Tamoore Arshad; Samarth Patel; Emily Lee; Somaya Albhaisi; Arun J Sanyal; R Todd Stravitz; Carolyn Driscoll; Richard K Sterling; Trevor Reichman; Chandra Bhati; Mohammad Shadab Siddiqui
Journal:  Hepatology       Date:  2019-03-29       Impact factor: 17.425

Review 2.  Angina in women.

Authors:  Nanette K Wenger
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

3.  Frequency of angina pectoris and secondary events in patients with stable coronary heart disease (from the Heart and Soul Study).

Authors:  Alexis L Beatty; John A Spertus; Mary A Whooley
Journal:  Am J Cardiol       Date:  2014-07-16       Impact factor: 2.778

4.  Chest pain and angina pectoris - or the ugly swan and the beautiful duckling.

Authors:  C van Tellingen
Journal:  Neth Heart J       Date:  2010-11       Impact factor: 2.380

5.  Feasibility and preliminary efficacy of acupuncture for angina in an underserved diverse population.

Authors:  Holli A DeVon; Glorieuse Uwizeye; Hui Yan Cai; Adhir R Shroff; Joan E Briller; Amer Ardati; Debra Hoppensteadt; Lauren Rountree; Judith M Schlaeger
Journal:  Acupunct Med       Date:  2021-12-02       Impact factor: 2.267

Review 6.  Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

7.  Comparative effectiveness of Di'ao Xin Xue Kang capsule and Compound Danshen tablet in patients with symptomatic chronic stable angina.

Authors:  Yanan Yu; Siyuan Hu; Guoxin Li; Jie Xue; Zhuoming Li; Xiangling Liu; Xiyan Yang; Bo Dong; Donghai Wang; Xiaofeng Wang; Shurong Liu; Jun Liu; Bingwei Chen; Liying Wang; Songshan Liu; Qiguang Chen; Chunti Shen; Zhong Wang; Yongyan Wang
Journal:  Sci Rep       Date:  2014-11-14       Impact factor: 4.379

Review 8.  Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial.

Authors:  Thomas J Ford; David Corcoran; Keith G Oldroyd; Margaret McEntegart; Paul Rocchiccioli; Stuart Watkins; Katriona Brooksbank; Sandosh Padmanabhan; Naveed Sattar; Andrew Briggs; Alex McConnachie; Rhian Touyz; Colin Berry
Journal:  Am Heart J       Date:  2018-04-03       Impact factor: 4.749

9.  Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease.

Authors:  Daniel M Blumenthal; Sidney E Howard; Jennifer Searl Como; Sandra M O'Keefe; Steven J Atlas; Daniel M Horn; Neil W Wagle; Jason H Wasfy; Robert W Yeh; Joshua P Metlay
Journal:  JAMA Netw Open       Date:  2021-06-01

10.  Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.

Authors:  Alon Eisen; Deepak L Bhatt; P Gabriel Steg; Kim A Eagle; Shinya Goto; Jianping Guo; Sidney C Smith; E Magnus Ohman; Benjamin M Scirica
Journal:  J Am Heart Assoc       Date:  2016-09-28       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.